Response to Drs Von Hoff and Renschler

Reply to Von Hoff and Renschler’s Letter to the Editor re: Ahn et al. A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis. Ther Adv Med Oncolhttps://doi.org/10.1177/175883401667601